|
|
|
|
LEADER |
01410nam a2200277 u 4500 |
001 |
EB002010723 |
003 |
EBX01000000000000001173622 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
220201 r ||| eng |
100 |
1 |
|
|a Gray, Casey
|
245 |
0 |
0 |
|a Fluoroquinolones for intra-abdominal infections
|h Elektronische Ressource
|b a review of clinical effectiveness, cost-effectiveness, and guidelines
|c Casey Gray, Hannah Loshak
|
246 |
3 |
1 |
|a Fluoroquinolones for the treatment of intra-abdominal Infections
|
250 |
|
|
|a Version 1.0
|
260 |
|
|
|a Ottawa
|b CADTH
|c April 25, 2019, 2019
|
300 |
|
|
|a 1 PDF file (36 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
700 |
1 |
|
|a Loshak, Hannah
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK544685
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 330
|
520 |
|
|
|a The objective of the current report is to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and evidence-based guidelines of fluoroquinolones for intra-abdominal infections
|